glp-1 parkinson's disease lancet Exenatide once weekly versus placebo in disease: a randomised, double-blind, placebo-controlled trial Frontiers | Neuroprotective effects of

Description

These studies highlight the importance of continued treatment for sustained success

For example, liraglutide, a GLP-1 receptor agonist, improved cognitive function in n = 19 patients with major depressive disorder (MDD) or bipolar disorder in a pilot randomised controlled trial (RCT) [16], whilst a systematic review and meta-analysis reported a pooled reduction in depressive symptoms with GLP-1 receptor agonists compared to other antidiabetic therapies [17]

I saw that he was a physician, so this added extra weight to his opinion - especially since physicians aren't particularly known for their awareness about the finer points of evidence-based nutrition

For years, the liver benefits of semaglutide have puzzled scientists

Combination or staged GLP-1 with nutrition therapy Given the existing adherence and cost challenges of GLP-1s coupled with significant weight regain after discontinuation, combination or staged therapy with intensive lifestyle management could promote greater efficacy, cost-effectiveness, and equitable obesity care [3,18,222,[271], [272], [273]]